Emergency room doctors at three area health systems collected data on patients who had experienced severe withdrawal symptoms ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

The FDA rejects over 1,300 drug applications yearly, often due to incomplete data or regulatory missteps, leading to millions in lost revenue and years of wasted research. But what if these delays ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.

One of the many areas that Elon Musk has taken his chainsaw to is the National Institutes of Health (NIH). His team has haphazardly ended grants and ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Christopher T. Robertson, JD, PhD, reviewed the history and ethical landscape of providing access to drugs before FDA ...